GRAIL, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GRAL research report →
Companygrail.com
GRAIL, Inc. , a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.
- CEO
- Robert Ragusa
- IPO
- 2024
- Employees
- 1,000
- HQ
- Menlo Park, CA, US
Price Chart
Valuation
- Market Cap
- $2.83B
- P/E
- -6.79
- P/S
- 18.15
- P/B
- 1.07
- EV/EBITDA
- -7.81
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -14.80%
- Op Margin
- -348.66%
- Net Margin
- -253.22%
- ROE
- -16.42%
- ROIC
- -15.24%
Growth & Income
- Revenue
- $147.17M · 17.18%
- Net Income
- $-408,351,000 · 79.85%
- EPS
- $-11.11 · 82.51%
- Op Income
- $-534,163,000
- FCF YoY
- 48.66%
Performance & Tape
- 52W High
- $118.84
- 52W Low
- $29.95
- 50D MA
- $52.42
- 200D MA
- $68.21
- Beta
- 3.04
- Avg Volume
- 972.74K
Get TickerSpark's AI analysis on GRAL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 15, 26 | MIZELL STEVEN | other | 396 |
| Apr 15, 26 | CHASE WILLIAM J | other | 408 |
| Apr 15, 26 | SUMME GREGORY L | other | 631 |
| Apr 8, 26 | Freidin Aaron | sell | 45,806 |
| Apr 8, 26 | RAGUSA ROBERT P | sell | 123,502 |
| Apr 8, 26 | Ofman Joshua J. | sell | 61,665 |
| Mar 5, 26 | Freidin Aaron | sell | 655 |
| Mar 9, 26 | Freidin Aaron | sell | 2,407 |
| Mar 9, 26 | Freidin Aaron | sell | 85 |
| Mar 5, 26 | Ofman Joshua J. | sell | 690 |
Our GRAL Coverage
We haven't published any research on GRAL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GRAL Report →